Physician

Gregory Walker, M.D., M.B.A.

According to 2025 Medicare claims, Gregory Walker, M.D., M.B.A. (NPI: 1487074084) practices dermatology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is OLIVER STREET 5.01(A) INC. (NPI: 1457695413; TIN: 461314303) and primary practice location at 76712-7935.

Walker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 773 traditional Medicare patients, billed 5,547 HCPCS/CPT codes, and received $500,009 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,281 prescription claims across 517 beneficiaries totaling $986,293 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 139 records totaling $2,562. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $73,732 to $500,009. Similarly, Part D prescription costs have risen steadily, from $10,340 to $986,293. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$250K$500K2018 Medicare payment: $73,732 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $381,919 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $290,531 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $353,479 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $400,263 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $404,811 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $500,009 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182321,234$73,732
20198075,508$381,919
20207634,224$290,531
20217475,002$353,479
20227894,735$400,263
20237835,167$404,811
20247735,547$500,009

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$493K$986K2015 Drug cost: $10,340 (USD; Tot_Drug_Cst)2016 Drug cost: $38,964 (USD; Tot_Drug_Cst)2017 Drug cost: $25,230 (USD; Tot_Drug_Cst)2018 Drug cost: $11,703 (USD; Tot_Drug_Cst)2019 Drug cost: $169,231 (USD; Tot_Drug_Cst)2020 Drug cost: $318,571 (USD; Tot_Drug_Cst)2021 Drug cost: $577,696 (USD; Tot_Drug_Cst)2022 Drug cost: $602,629 (USD; Tot_Drug_Cst)2023 Drug cost: $858,261 (USD; Tot_Drug_Cst)2024 Drug cost: $986,293 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201583140$10,340
2016132320$38,964
2017121244$25,230
2018164329$11,703
20194651,142$169,231
20204291,213$318,571
20214301,136$577,696
20224001,096$602,629
20234451,125$858,261
20245171,281$986,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks227293$510
11102Biopsy of related skin growth, first growth201245$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more468678$63
17000Destruction of precancer skin growth, 1 growth360514$41
17003Destruction of precancer skin growth, 2-14 growths3052,067$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa221,848$446,986
Cosentyx Sensoready (2 Pens)Secukinumab16448$185,467
OtezlaApremilast18660$106,084
Humira(Cf) PenAdalimumab14392$94,397
Dupixent PenDupilumab17462$63,642

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.139$2,562ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gregory Walker, M.D., M.B.A.?

Tedicare shows public-source Medicare data for Gregory Walker, M.D., M.B.A. (NPI 1487074084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Walker, M.D., M.B.A. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregory Walker, M.D., M.B.A.?

Gregory Walker, M.D., M.B.A. is linked to OLIVER STREET 5.01(A) INC. (billing NPI 1457695413) in the available physician profile data.

Does Gregory Walker, M.D., M.B.A. have Open Payments data?

Gregory Walker, M.D., M.B.A. has 139 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.